BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
Home » Authors » John Brosky

Articles by John Brosky

Medical devices in spotlight as driver for economic growth

Jan. 1, 2011
By John Brosky

Patient data exchanged by 9 European nations

Dec. 15, 2010
By John Brosky

Report from Europe: Heart valve surgery overused in Europe according to studies

Dec. 6, 2010
By John Brosky
PARIS — Artificial heart valves were invented and first implanted before regulations for such devices were created. (Medical Device Daily)
Read More

Fresh approach marks launch of novel in vitro diagnostics

Dec. 1, 2010
By John Brosky

Lack of scanners, PACS plunges France in crisis

Dec. 1, 2010
By John Brosky

China to dominate low-end European ultrasound market

Dec. 1, 2010
By John Brosky
DÜSSELDORF, Germany — Competition is over-heating in the low end of the ultrasound market in Europe and following a brutal pricing war, watch for a Chinese company to emerge as the dominant player in the next few years. (Medical Device Daily)
Read More

Ultrasound partners bring endoscopes to next level

Nov. 29, 2010
By John Brosky
DÜSSELDORF, Germany – Partnering with ultrasound companies, leading endoscope makers are bringing advanced diagnostics deep inside the human body enhancing not only the ability to see diseased tissue but to treat in the same intervention. (Medical Device Daily)
Read More

Maquet and Philips reveal 'truly hybrid' operating room

Nov. 24, 2010
By John Brosky
DÜSSELDORF, Germany – In a mad rush to support minimally invasive surgeries, too many fake hybrid operating rooms (ORs) have been built, according to Maquet (Rastatt, Germany). (Medical Device Daily)
Read More

Medical devices in spotlight as driver for economic growth

Nov. 23, 2010
By John Brosky
DÜSSELDORF, Germany – Lights, cameras and political action! For the first time in its 40-year history, the world's largest trade fair for medical technologies found itself at center stage as the German Chancellor, Angela Merkel, arrived for the opening ceremonies at the massive Düsseldorf Messe. (Medical Device Daily)
Read More

Draeger monitors to feature novel imaging modality

Nov. 23, 2010
By John Brosky
Previous 1 2 … 51 52 53 54 55 56 57 58 59 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 30, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing